TriPath Imaging to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference

BURLINGTON, N.C., June 8  /PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) today announced that its management is scheduled to speak at the Needham & Company, LLC Fifth Annual Biotechnology and Medical Technology Conference in New York City at the New York Palace Hotel on Thursday, June 15, 2006 at 10:00 a.m. ET about the Company's financial performance, business and development highlights and future expectations.

An audio web cast of the presentation will be available live online via TriPath Imaging's website at http://www.tripathimaging.com/ and will be archived for at least two weeks.

TriPath Imaging, Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment.  TriPath Oncology, a wholly owned subsidiary of TriPath Imaging, develops and manages the market introduction of molecular diagnostic products for malignant melanoma and cancers of the cervix, breast, ovary and prostate.

   Contact
   Stephen P. Hall
   Chief Financial Officer
   336-290-8721


DATASOURCE: TriPath Imaging, Inc.



CONTACT:  Stephen P. Hall, Chief Financial Officer of TriPath Imaging,

Inc., [phone]



Web site:  http://www.tripathimaging.com/

Copyright